Harbourvest Partners’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,468
| Closed | -$46.7K | – | 28 |
|
|
2024
Q3 | $46.7K | Hold |
2,468
| – | – | 0.02% | 29 |
|
|
2024
Q2 | $35.7K | Hold |
2,468
| – | – | 0.02% | 34 |
|
|
2024
Q1 | $38.2K | Hold |
2,468
| – | – | 0.02% | 44 |
|
|
2023
Q4 | $69.1K | Hold |
2,468
| – | – | 0.02% | 48 |
|
|
2023
Q3 | $117K | Hold |
2,468
| – | – | 0.04% | 51 |
|
|
2023
Q2 | $236K | Hold |
2,468
| – | – | 0.07% | 47 |
|
|
2023
Q1 | $280K | Hold |
2,468
| – | – | 0.09% | 48 |
|
|
2022
Q4 | $276K | Hold |
2,468
| – | – | 0.09% | 48 |
|
|
2022
Q3 | $317K | Hold |
2,468
| – | – | 0.1% | 53 |
|
|
2022
Q2 | $169K | Hold |
2,468
| – | – | 0.06% | 55 |
|
|
2022
Q1 | $351K | Hold |
2,468
| – | – | 0.07% | 55 |
|
|
2021
Q4 | $411K | Hold |
2,468
| – | – | 0.05% | 51 |
|
|
2021
Q3 | $344K | Hold |
2,468
| – | – | 0.03% | 47 |
|
|
2021
Q2 | $1.18M | Hold |
2,468
| – | – | 0.11% | 32 |
|
|
2021
Q1 | $1.02M | Sell |
2,468
-1,727
| -41% | -$711K | 0.14% | 24 |
|
|
2020
Q4 | $2.06M | Buy |
+4,195
| New | +$2.06M | 0.8% | 12 |
|